Vanguard Group’s TriSalus Life Sciences TLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.44M | Buy |
814,389
+327,771
| +67% | +$1.79M | ﹤0.01% | 3255 |
|
|
2025
Q1 | $2.69M | Buy |
486,618
+10,326
| +2% | +$57K | ﹤0.01% | 3386 |
|
|
2024
Q4 | $2.39M | Buy |
476,292
+60,154
| +14% | +$301K | ﹤0.01% | 3507 |
|
|
2024
Q3 | $1.92M | Hold |
416,138
| – | – | ﹤0.01% | 3569 |
|
|
2024
Q2 | $2.3M | Buy |
416,138
+248,979
| +149% | +$1.37M | ﹤0.01% | 3514 |
|
|
2024
Q1 | $1.63M | Buy |
167,159
+2,023
| +1% | +$19.7K | ﹤0.01% | 3657 |
|
|
2023
Q4 | $1.4M | Buy |
+165,136
| New | +$1.4M | ﹤0.01% | 3721 |
|